TVGNW Earnings Tevogen Bio Holdings Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–14 of 14
| Q1 2026 | 2026-03-31 | -1.61 | 2026-05-15 | 10-Q |
| FY 2025 | 2025-12-31 | -8.08 | 2026-03-31 | 10-K |
| Q3 2025 | 2025-09-30 | -0.12 | 2025-11-14 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.09 | 2025-08-14 | 10-Q |
| Q1 2026 | 2025-03-31 | -3.25 | 2026-05-15 | 10-Q |
| FY 2025 | 2024-12-31 | -3.50 | 2026-03-31 | 10-K |
| Q3 2025 | 2024-09-30 | -0.01 | 2025-11-14 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.29 | 2025-08-14 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.26 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -2.44 | 2025-04-02 | 10-K |
| Q3 2024 | 2023-09-30 | -2.30 | 2024-11-19 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.44 | 2024-08-14 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.26 | 2024-05-28 | 10-Q |
| Q1 2023 | 2022-03-31 | 0.00 | 2023-05-22 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.